Iniciar Sesión Regístrate abrir menu

Bibliografía Científica

Artículos por temáticas

En este apartado encontrará una actualización mensual de Trastornos del Movimiento

9431 ARTÍCULOS , VIENDO DEL 3826 AL 3840

Study protocol for a single-blind randomised controlled trial to evaluate the clinical effects of an Integrated Qigong exercise intervention on freezing of gait in Parkinson's disease

Li Z, Zhuang J, Jiang Y, Xiao G, Jie K, Wang T, Yin W, Zhang Y, Wang Z.

BMJ Open. 2019 Sep 12;9(9):e028869. doi: 10.1136/bmjopen-2018-028869.

Effectiveness of home-based and remotely supervised aerobic exercise in Parkinson's disease: a double-blind, randomised controlled trial

van der Kolk NM, de Vries NM, Kessels RPC, Joosten H, Zwinderman AH, Post B, Bloem BR.

Lancet Neurol. 2019 Nov;18(11):998-1008. doi: 10.1016/S1474-4422(19)30285-6. Epub 2019 Sep 11.

Short Versus Conventional Pulse-Width Deep Brain Stimulation in Parkinson's Disease: A Randomized Crossover Comparison

Dayal V, Grover T, Tripoliti E, Milabo C, Salazar M, Candelario-McKeown J, Athauda D, Zrinzo L, Akram H, Hariz M, Limousin P, Foltynie T.

Mov Disord. 2020 Jan;35(1):101-108. doi: 10.1002/mds.27863. Epub 2019 Sep 30.

Fast Orthostatic Tremor in Parkinson's Disease: Case Report and Comprehensive Review of Literature

Chaithra SP, Prasad S, Holla VV, Pal PK.

Tremor Other Hyperkinet Mov (N Y). 2019 Sep 16;9. doi: 10.7916/tohm.v0.670. eCollection 2019.

Exercise increases caudate dopamine release and ventral striatal activation in Parkinson's disease

Sacheli MA, Neva JL, Lakhani B, Murray DK, Vafai N, Shahinfard E, English C, McCormick S, Dinelle K, Neilson N, McKenzie J, Schulzer M, McKenzie DC, Appel-Cresswell S, McKeown MJ, Boyd LA, Sossi V, Stoessl AJ.

Mov Disord. 2019 Dec;34(12):1891-1900. doi: 10.1002/mds.27865. Epub 2019 Oct 4.

Simvastatin as a neuroprotective treatment for Parkinson's disease (PD STAT): protocol for a double-blind, randomised, placebo-controlled futility study

Carroll CB, Webb D, Stevens KN, Vickery J, Eyre V, Ball S, Wyse R, Webber M, Foggo A, Zajicek J, Whone A, Creanor S.

BMJ Open. 2019 Oct 7;9(10):e029740. doi: 10.1136/bmjopen-2019-029740.

Chemosensory dysfunction in neurodegenerative diseases

Doty RL, Hawkes CH.

Handb Clin Neurol. 2019;164:325-360. doi: 10.1016/B978-0-444-63855-7.00020-4.

Role of deep brain stimulation therapy in the magnetic resonance-guided high-frequency focused ultrasound era: current situation and future prospects

Fernandez-Garcia C, Alonso-Frech F, Monje MHG, Matias-Guiu J.

Expert Rev Neurother. 2020 Jan;20(1):7-21. doi: 10.1080/14737175.2020.1677465. Epub 2019 Oct 22.

Parkinson disease

Balestrino R, Schapira AHV.

Eur J Neurol. 2020 Jan;27(1):27-42. doi: 10.1111/ene.14108. Epub 2019 Nov 27.

Juvenile Parkinson Disease

Anwar A, Saleem S, Akhtar A, Ashraf S, Ahmed MF.

Cureus. 2019 Aug 17;11(8):e5409. doi: 10.7759/cureus.5409.

The Genetic Architecture of Parkinson Disease in Spain: Characterizing Population-Specific Risk, Differential Haplotype Structures, and Providing Etiologic Insight

Bandres-Ciga S, Ahmed S, Sabir MS, Blauwendraat C, Adarmes-Gómez AD, Bernal-Bernal I, Bonilla-Toribio M, Buiza-Rueda D, Carrillo F, Carrión-Claro M, Gómez-Garre P, Jesús S, Labrador-Espinosa MA, Macias D, Méndez-Del-Barrio C, Periñán-Tocino T, Tejera-Parrado C, Vargas-González L, Diez-Fairen M, Alvarez I, Tartari JP, Buongiorno M, Aguilar M, Gorostidi A, Bergareche JA, Mondragon E, Vinagre-Aragon A, Croitoru I, Ruiz-Martínez J, Dols-Icardo O, Kulisevsky J, Marín-Lahoz J, Pagonabarraga J, Pascual-Sedano B, Ezquerra M, Cámara A, Compta Y, Fernández M, Fernández-Santiago R, Muñoz E, Tolosa E, Valldeoriola F, Gonzalez-Aramburu I, Sanchez Rodriguez A, Sierra M, Menéndez-González M, Blazquez M, Garcia C, Suarez-San Martin E, García-Ruiz P, Martínez-Castrillo JC, Vela-Desojo L, Ruz C, Barrero FJ, Escamilla-Sevilla F, Mínguez-Castellanos A, Cerdan D, Tabernero C, Gomez Heredia MJ, Perez Errazquin F, Romero-Acebal M, Feliz C, Lopez-Sendon JL, Mata M, Martínez Torres I, Kim JJ, Dalgard CL; American Genome Center; Brooks J, Saez-Atienzar S, Gibbs JR, Jorda R, Botia JA, Bonet-Ponce L, Morrison KE, Clarke C, Tan M, Morris H, Edsall C, Hernandez D, Simon-Sanchez J, Nalls MA, Scholz SW, Jimenez-Escrig A, Duarte J, Vives F, Duran R, Hoenicka J, Alvarez V, Infante J, Marti MJ, Clarimón J, López de Munain A, Pastor P, Mir P, Singleton A; International Parkinson Disease Genomics Consortium.

Mov Disord. 2019 Dec;34(12):1851-1863. doi: 10.1002/mds.27864. Epub 2019 Oct 29.

Pathological Influences on Clinical Heterogeneity in Lewy Body Diseases

Coughlin DG, Hurtig HI, Irwin DJ.

Mov Disord. 2020 Jan;35(1):5-19. doi: 10.1002/mds.27867. Epub 2019 Oct 29.

Does a Sway-Based Mobile Application Predict Future Falls in People With Parkinson Disease?

Fiems CL, Miller SA, Buchanan N, Knowles E, Larson E, Snow R, Moore ES.

Arch Phys Med Rehabil. 2020 Mar;101(3):472-478. doi: 10.1016/j.apmr.2019.09.013. Epub 2019 Oct 24.

Animal Models for Parkinson's Disease Research: Trends in the 2000s

Kin K, Yasuhara T, Kameda M, Date I.

Int J Mol Sci. 2019 Oct 30;20(21):5402. doi: 10.3390/ijms20215402.

Melatonin for rapid eye movement sleep behavior disorder in Parkinson's disease: A randomised controlled trial

Gilat M, Coeytaux Jackson A, Marshall NS, Hammond D, Mullins AE, Hall JM, Fang BAM, Yee BJ, Wong KKH, Grunstein RR, Lewis SJG.

Mov Disord. 2020 Feb;35(2):344-349. doi: 10.1002/mds.27886. Epub 2019 Oct 31.

Actualización mensual Regístrese para recibir los avisos de actualización

Si quiere recomendar un artículo/publicación para completar este apartado puede hacerlo a través del formulario de contacto para su valoración.

En ningún caso la información facilitada constituye asesoramiento por parte de Zambon

Con el aval de:

Logo SEN Logo WIS

En colaboración con:

Zambon Neurociencias